-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
-
Summary
-
Eupraxia Pharmaceuticals Inc. quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q4 2023.
- Eupraxia Pharmaceuticals Inc. Liabilities and Equity for the quarter ending December 31, 2023 was $20.3M, a 5.98% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)